Peak Bio
Stock Forecast, Prediction & Price Target
Peak Bio Financial Estimates
Peak Bio Revenue Estimates
Peak Bio EBITDA Estimates
Peak Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $528.30K N/A | $607.68K 15.02% | $367.87K -39.46% | Avg: $924.78K Low: $924.78K High: $924.78K avg. 151.38% | |||
Net Income
% change YoY
| $-8.29M N/A | $-13.08M -57.83% | $-1.25K 99.99% | Avg: $-28.33M Low: $-28.33M High: $-28.33M avg. -2250809.29% | |||
EBITDA
% change YoY
| $-8.88M N/A | $-11.87M -33.63% | $-1.35K 99.98% | Avg: $-924.78K Low: $-924.78K High: $-924.78K avg. -68099.11% | |||
EPS
% change YoY
| -$0.48 N/A | -$0.74 -54.16% | $0 100% | Avg: -$1.6 Low: -$1.6 High: -$1.6 avg. 0% | |||
Operating Expenses
% change YoY
| $9.59M N/A | $12.45M 29.82% | $1.24K -99.98% | Avg: $8.65M Low: $8.65M High: $8.65M avg. 692704.32% | |||
FAQ
What is Peak Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -2250809.29% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -28.33M, average is -28.33M and high is -28.33M.
What is Peak Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 151.38% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $924.78K, average is $924.78K and high is $924.78K.
What is Peak Bio stock earnings per share growth forecast?
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.6, average is -$1.6 and high is $-1.6.